Skip to search formSkip to main contentSkip to account menu

azomycin

Known as: 2-nitroimidazole 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2003
Review
2003
The measurement of pathologically low levels of tissue pO2 is an important diagnostic goal for determining the prognosis of many… 
Highly Cited
2000
Highly Cited
2000
UNLABELLED Hypoxia in tumors is believed to be an important cause of local failure of radiotherapy in certain types of cancer… 
Highly Cited
1996
Highly Cited
1996
UNLABELLED The 99mTc-labeled 2-nitroimidazole derivative BMS181321, previously studied in experimental models of myocardial and… 
Highly Cited
1996
Highly Cited
1996
Tumour oxygenation status in individual patients may be assessed using the bioreduction and linkage of 2-nitroimidazole markers… 
Highly Cited
1991
Highly Cited
1991
1-(5-Iodo-5-deoxy-beta-D-arabinofuranosyl)-2-nitroimidazole (IAZA) has been synthesised and labeled with 125I. Radioiodinated… 
Highly Cited
1978
Highly Cited
1978
In vitro studies with CHO cells indicate that the 2-nitroimidazole, misonidazole, is markedly more toxic under hypoxic conditions… 
Highly Cited
1974
Highly Cited
1974
Local tumour control has been determined at 150 days after single doses of 240 kV x-rays given with or without 1 mg/g body weight…